Skip to main content
Clinical Trials/CTRI/2017/10/010292
CTRI/2017/10/010292
Completed
未知

Safety and efficacy profile of systemic corticosteroids and isotretinoin versus systemic corticosteroids alone in cutaneous lichen planus- A hospital based prospective double blind placebo controlled comparative study

Krishna Institute of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Krishna Institute of Medical Sciences
Enrollment
60
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • A.Must give written consent before any treatment commenced.
  • B.Must be diagnosed to be suffering from cutaneous lichen planus either by clinical examination or histopathology if required.
  • C.Must have generalised lichen planus involving minimum 20% body surface area or cases of palmoplantar lichen planus
  • D.Must stop any other modality of treatment, two months prior to the inclusion in study.
  • E.Must be able and willing, in the view of investigator, to comply all study procedure.

Exclusion Criteria

  • A. Patient having only oral lichen planus, genital lichen planus, nail lichen planus, follicular lichen planus, actinic lichen planus, lichen planus pigmentosus, lichen planus pemphigoides,
  • B. Patient with hypersensitivity to drug or patient intolerant to the study medication.
  • C. Pregnant and lactating patient.
  • D. Patient with unrealistic expectations.
  • E. Not willing for regular follow up.
  • F. Patient with clinically significant cardiovascular, haematological, pancreatic, metabolic neurological or any other laboratory anomaly, which in the judgement of investigator, would interfere in participation in study or proper evaluation.
  • G. Patient on any other systemic drugs therapy which in the judgement of investigator may interfere with interpretation of results.
  • H. Patient having history of tuberculosis or chest X\-ray showing evidence of any infective pathology.
  • I. Immunocompromised patients

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 3
Comparison of the effect of Budesonide nasal spray, Betamethasone nasal drop, and Budesonide nebulizing suspension on sinonasal polyposis recurrence
IRCT20201021049095N1Shahid Beheshti University of Medical Sciences108
Active, not recruiting
Phase 1
Efficacy and Safety of corticoids in patients with adult respiratory distress syndrome (ARDS) secondary to coronavirus infection.Adult respiratory distress syndrome (ARDS) secondary to SARS-CoV-2Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
EUCTR2020-001307-16-ESFundación para la Investigación Biomédica Hospital Ramón y Cajal104
Completed
Not Applicable
Groningen Hand and Wrist Injection Therapy Trial (HAWITT)Tenosynovitis, carpal tunnel syndromeNervous System DiseasesMononeuropathies of upper limb
ISRCTN53171398niversity Medical Centre Groningen (UMCG) (Netherlands)120
Recruiting
Phase 3
Efficacy of steroid treatment on heart blocks secondary to heart valve surgeryAdvanced atrioventricular block following heart valve surgery.Atrioventricular and left bundle-branch block
IRCT20180430039488N1Tehran Heart Center150
Recruiting
Not Applicable
Efficacy and safety of corticosteroid monotherapy versus combination therapy of corticosteroid and tacrolimus for patients with anti-aminoacyl-tRNA synthetase antibody-positive polymyositis/dermatomyositis-associated interstitial lung disease: a prospective randomized multicenter clinical trialanti-aminoacyl-tRNA synthetase antibody-positive polymyositis/dermatomyositis/clinically amyopathic dermatomyositis-associated interstitial lung disease
JPRN-UMIN000032022Hamamatsu University School of Medicine66